UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM N-Q
QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED
MANAGEMENT INVESTMENT COMPANY
_______________________________
Investment Company Act file number: 811-00642
Deutsche International Fund, Inc.
(Exact name of registrant as specified in charter)
345 Park Avenue
New York, NY 10154
(Address of principal executive offices) (Zip code)
Paul Schubert
60 Wall Street
New York, NY 10005
(Name and address of agent for service)
Registrant's telephone number, including area code: (212) 250-3220
Date of fiscal year end: 10/31
Date of reporting period: 7/31/2015
ITEM 1. | SCHEDULE OF INVESTMENTS |
Investment Portfolio | as of July 31, 2015 (Unaudited) |
Deutsche Global Equity Fund
Shares | Value ($) | |||||||||
Common Stocks 97.2% | ||||||||||
Belgium 0.8% | ||||||||||
Anheuser-Busch InBev NV (Cost $82,015) | 2,300 | 275,483 | ||||||||
Brazil 1.0% | ||||||||||
Estacio Participacoes SA | 36,000 | 149,301 | ||||||||
Itau Unibanco Holding SA (ADR) (Preferred) | 22,000 | 190,960 | ||||||||
(Cost $509,525) | 340,261 | |||||||||
Canada 6.5% | ||||||||||
Agnico Eagle Mines Ltd. | 9,000 | 199,170 | ||||||||
Alimentation Couche-Tard, Inc. "B" | 15,000 | 669,458 | ||||||||
Brookfield Asset Management, Inc. "A" | 24,000 | 837,894 | ||||||||
Canadian Pacific Railway Ltd. | 2,700 | 434,651 | ||||||||
(Cost $1,663,846) | 2,141,173 | |||||||||
Denmark 1.3% | ||||||||||
Jyske Bank AS (Registered)* (Cost $385,929) | 8,000 | 417,226 | ||||||||
France 4.0% | ||||||||||
JC Decaux SA (a) | 14,800 | 566,516 | ||||||||
Pernod Ricard SA | 3,000 | 359,347 | ||||||||
Vivendi SA | 15,000 | 394,443 | ||||||||
(Cost $1,314,597) | 1,320,306 | |||||||||
Germany 4.7% | ||||||||||
BASF SE | 3,500 | 301,958 | ||||||||
Fresenius Medical Care AG & Co. KGaA | 7,500 | 611,344 | ||||||||
LANXESS AG | 11,000 | 635,447 | ||||||||
(Cost $1,308,195) | 1,548,749 | |||||||||
Indonesia 0.9% | ||||||||||
PT Bank Negara Indonesia Persero Tbk (Cost $391,601) | 800,000 | 281,028 | ||||||||
Ireland 6.6% | ||||||||||
Allergan PLC*(b) | 2,700 | 894,105 | ||||||||
Glanbia PLC | 27,000 | 563,995 | ||||||||
Kerry Group PLC "A" | 5,000 | 379,720 | ||||||||
Shire PLC | 4,000 | 354,624 | ||||||||
(Cost $1,454,778) | 2,192,444 | |||||||||
Israel 0.6% | ||||||||||
Mobileye NV* (b) (Cost $143,587) | 3,500 | 210,350 | ||||||||
Luxembourg 1.8% | ||||||||||
Eurofins Scientific (Cost $406,396) | 1,800 | 590,962 | ||||||||
Malaysia 0.7% | ||||||||||
IHH Healthcare Bhd. (Cost $188,805) | 145,000 | 227,700 | ||||||||
Mexico 1.1% | ||||||||||
Fomento Economico Mexicano SAB de CV (ADR) (Cost $362,361) | 4,000 | 362,560 | ||||||||
Netherlands 1.2% | ||||||||||
Sensata Technologies Holding NV* (b) (Cost $378,269) | 8,000 | 410,560 | ||||||||
Norway 3.6% | ||||||||||
Gjensidige Forsikring ASA | 33,000 | 529,900 | ||||||||
Marine Harvest ASA | 55,000 | 678,412 | ||||||||
(Cost $1,181,471) | 1,208,312 | |||||||||
Philippines 1.8% | ||||||||||
GT Capital Holdings, Inc. | 11,000 | 337,019 | ||||||||
Universal Robina Corp. | 65,000 | 271,857 | ||||||||
(Cost $566,218) | 608,876 | |||||||||
South Africa 2.3% | ||||||||||
Aspen Pharmacare Holdings Ltd.* | 10,000 | 293,495 | ||||||||
MTN Group Ltd. | 28,000 | 466,051 | ||||||||
(Cost $832,216) | 759,546 | |||||||||
Sweden 5.0% | ||||||||||
Assa Abloy AB "B" | 19,500 | 395,798 | ||||||||
Atlas Copco AB "A" | 7,000 | 191,335 | ||||||||
Hennes & Mauritz AB "B" | 6,700 | 267,428 | ||||||||
Meda AB "A" | 15,500 | 252,598 | ||||||||
Svenska Cellulosa AB "B" | 8,000 | 228,238 | ||||||||
Telefonaktiebolaget LM Ericsson "B" | 30,000 | 321,940 | ||||||||
(Cost $1,594,297) | 1,657,337 | |||||||||
Switzerland 5.2% | ||||||||||
Galenica AG (Registered) | 700 | 797,491 | ||||||||
Lonza Group AG (Registered)* | 3,000 | 435,695 | ||||||||
Nestle SA (Registered) | 6,500 | 492,860 | ||||||||
(Cost $1,286,388) | 1,726,046 | |||||||||
United Kingdom 5.5% | ||||||||||
Aon PLC (b) | 4,000 | 403,080 | ||||||||
AVEVA Group PLC | 7,000 | 240,705 | ||||||||
Compass Group PLC | 27,000 | 432,507 | ||||||||
Halma PLC | 21,000 | 248,373 | ||||||||
Smith & Nephew PLC | 16,000 | 297,493 | ||||||||
Spirax-Sarco Engineering PLC | 3,857 | 199,732 | ||||||||
(Cost $1,748,595) | 1,821,890 | |||||||||
United States 42.6% | ||||||||||
Acadia Healthcare Co., Inc.* | 4,300 | 343,054 | ||||||||
Alliance Data Systems Corp.* | 2,500 | 687,600 | ||||||||
Amphenol Corp. "A" | 17,000 | 958,970 | ||||||||
Applied Materials, Inc. | 18,000 | 312,480 | ||||||||
Bristol-Myers Squibb Co. | 7,000 | 459,480 | ||||||||
CBRE Group, Inc. "A"* | 9,000 | 341,730 | ||||||||
Cepheid, Inc.* | 3,000 | 166,770 | ||||||||
Cerner Corp.* (a) | 6,000 | 430,320 | ||||||||
Citrix Systems, Inc.* | 3,500 | 264,635 | ||||||||
Danaher Corp. | 6,500 | 595,140 | ||||||||
eBay, Inc.* | 6,500 | 182,780 | ||||||||
Ecolab, Inc. | 5,500 | 636,955 | ||||||||
Envision Healthcare Holdings, Inc.* | 9,000 | 403,200 | ||||||||
Evolent Health, Inc. "A"* | 7,480 | 159,548 | ||||||||
Express Scripts Holding Co.* | 3,940 | 354,876 | ||||||||
Exxon Mobil Corp. | 3,300 | 261,393 | ||||||||
Harman International Industries, Inc. | 4,300 | 462,938 | ||||||||
HealthStream, Inc.* | 8,500 | 238,510 | ||||||||
JPMorgan Chase & Co. | 13,000 | 890,890 | ||||||||
Las Vegas Sands Corp. (a) | 8,000 | 448,320 | ||||||||
LKQ Corp.* | 11,000 | 346,060 | ||||||||
MasterCard, Inc. "A" | 7,000 | 681,800 | ||||||||
Mead Johnson Nutrition Co. | 3,500 | 309,365 | ||||||||
Nielsen NV | 7,500 | 363,450 | ||||||||
Noble Energy, Inc. | 13,500 | 475,605 | ||||||||
Omnicare, Inc. | 2,500 | 242,125 | ||||||||
Pall Corp. | 4,500 | 569,025 | ||||||||
PayPal Holdings, Inc.* | 6,500 | 251,550 | ||||||||
Praxair, Inc. | 3,600 | 410,904 | ||||||||
Press Ganey Holdings, Inc.* | 10,000 | 313,100 | ||||||||
Schlumberger Ltd. | 5,000 | 414,100 | ||||||||
Time Warner, Inc. | 5,000 | 440,200 | ||||||||
Union Pacific Corp. | 2,000 | 195,180 | ||||||||
United Technologies Corp. | 5,000 | 501,550 | ||||||||
(Cost $12,365,528) | 14,113,603 | |||||||||
Total Common Stocks (Cost $28,164,617) | 32,214,412 | |||||||||
Securities Lending Collateral 2.6% | ||||||||||
Daily Assets Fund Institutional, 0.18% (c) (d) (Cost $878,606) | 878,606 | 878,606 | ||||||||
Cash Equivalents 2.6% | ||||||||||
Central Cash Management Fund, 0.10% (c) (Cost $848,049) | 848,049 | 848,049 | ||||||||
% of Net Assets |
Value ($) | |||||||||
Total Investment Portfolio (Cost $29,891,272) † | 102.4 | 33,941,067 | ||||||||
Other Assets and Liabilities, Net | (2.4) | (810,031) | ||||||||
Net Assets | 100.0 | 33,131,036 | ||||||||
For information on the Fund's policies regarding the valuation of investments and other significant accounting policies, please refer to the Fund's most recent semi-annual or annual financial statements. |
* | Non-income producing security. |
† | The cost for federal income tax purposes was $29,938,236. At July 31, 2015, net unrealized appreciation for all securities based on tax cost was $4,002,831. This consisted of aggregate gross unrealized appreciation for all securities in which there was an excess of value over tax cost of $5,182,773 and aggregate gross unrealized depreciation for all securities in which there was an excess of tax cost over value of $1,179,942. |
(a) | All or a portion of these securities were on loan. In addition, "Other Assets and Liabilities, Net" may include pending sales that are also on loan. The value of securities loaned at July 31, 2015 amounted to $840,363, which is 2.5% of net assets. |
(b) | Listed on the New York Stock Exchange. |
(c) | Affiliated fund managed by Deutsche Investment Management Americas Inc. The rate shown is the annualized seven-day yield at period end. |
(d) | Represents collateral held in connection with securities lending. Income earned by the Fund is net of borrower rebates. |
ADR: American Depositary Receipt |
At July 31, 2015 the Deutsche Global Equity Fund had the following sector diversification: |
Sector Diversification | Market Value ($) | As a % of Common Stocks | ||||||
Health Care | 7,866,490 | 24.4 | % | |||||
Consumer Staples | 4,591,295 | 14.3 | % | |||||
Information Technology | 4,361,183 | 13.5 | % | |||||
Financials | 4,229,727 | 13.1 | % | |||||
Industrials | 3,856,421 | 12.0 | % | |||||
Consumer Discretionary | 3,507,713 | 10.9 | % | |||||
Materials | 2,184,434 | 6.8 | % | |||||
Energy | 1,151,098 | 3.6 | % | |||||
Telecommunication Services | 466,051 | 1.4 | % | |||||
Total | 32,214,412 | 100.0 | % | |||||
Sector diversification is subject to change. |
Fair Value Measurements
Various inputs are used in determining the value of the Fund's investments. These inputs are summarized in three broad levels. Level 1 includes quoted prices in active markets for identical securities. Level 2 includes other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, and credit risk). Level 3 includes significant unobservable inputs (including the Fund's own assumptions in determining the fair value of investments). The level assigned to the securities valuations may not be an indication of the risk or liquidity associated with investing in those securities
The following is a summary of the inputs used as of July 31, 2015 in valuing the Fund's investments
Assets | Level 1 | Level 2 | Level 3 | Total | ||||||||||||
Common Stocks | ||||||||||||||||
Belgium | $ | — | $ | 275,483 | $ | — | $ | 275,483 | ||||||||
Brazil | 340,261 | — | — | 340,261 | ||||||||||||
Canada | 2,141,173 | — | — | 2,141,173 | ||||||||||||
Denmark | — | 417,226 | — | 417,226 | ||||||||||||
France | — | 1,320,306 | — | 1,320,306 | ||||||||||||
Germany | — | 1,548,749 | — | 1,548,749 | ||||||||||||
Indonesia | — | 281,028 | — | 281,028 | ||||||||||||
Ireland | 894,105 | 1,298,339 | — | 2,192,444 | ||||||||||||
Israel | 210,350 | — | — | 210,350 | ||||||||||||
Luxembourg | — | 590,962 | — | 590,962 | ||||||||||||
Malaysia | — | 227,700 | — | 227,700 | ||||||||||||
Mexico | 362,560 | — | — | 362,560 | ||||||||||||
Netherlands | 410,560 | — | — | 410,560 | ||||||||||||
Norway | — | 1,208,312 | — | 1,208,312 | ||||||||||||
Philippines | — | 608,876 | — | 608,876 | ||||||||||||
South Africa | — | 759,546 | — | 759,546 | ||||||||||||
Sweden | — | 1,657,337 | — | 1,657,337 | ||||||||||||
Switzerland | — | 1,726,046 | — | 1,726,046 | ||||||||||||
United Kingdom | 403,080 | 1,418,810 | — | 1,821,890 | ||||||||||||
United States | 14,113,603 | — | — | 14,113,603 | ||||||||||||
Short-Term Investments (e) | 1,726,655 | — | — | 1,726,655 | ||||||||||||
Total | $ | 20,602,347 | $ | 13,338,720 | $ | — | $ | 33,941,067 |
There have been no transfers between fair value measurement levels during the period ended July 31, 2015. | |
(e) | See Investment Portfolio for additional detailed categorizations. |
ITEM 2. | CONTROLS AND PROCEDURES | |
(a) | The Chief Executive and Financial Officers concluded that the Registrant’s Disclosure Controls and Procedures are effective based on the evaluation of the Disclosure Controls and Procedures as of a date within 90 days of the filing date of this report. | |
(b) | There have been no changes in the registrant’s internal control over financial reporting that occurred during the registrant’s last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal controls over financial reporting. | |
ITEM 3. | EXHIBITS | |
Certification pursuant to Rule 30a-2(a) under the Investment Company Act of 1940 (17 CFR 270.30a-2(a)) is filed and attached hereto as Exhibit 99.CERT. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Registrant: | Deutsche Global Equity Fund, a series of Deutsche International Fund, Inc. |
By: |
/s/Brian E. Binder Brian E. Binder President |
Date: | September 22, 2015 |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
By: |
/s/Brian E. Binder Brian E. Binder President |
Date: | September 22, 2015 |
By: |
/s/Paul Schubert Paul Schubert Chief Financial Officer and Treasurer |
Date: | September 22, 2015 |
CERTIFICATIONS
I, Brian E. Binder, certify that:
1. | I have reviewed this report on Form N-Q of Deutsche Global Equity Fund, a series of Deutsche International Fund, Inc.; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed; |
4. | The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have: |
(a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
(b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
(c) | Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation; and |
(d) | Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and |
5. | The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): |
(a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and |
(b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
By: |
/s/Brian E. Binder Brian E. Binder President |
Date: | September 22, 2015 |
CERTIFICATIONS
I, Paul Schubert, certify that:
1. | I have reviewed this report on Form N-Q of Deutsche Global Equity Fund, a series of Deutsche International Fund, Inc.; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed; |
4. | The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have: |
(a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
(b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
(c) | Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation; and |
(d) | Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and |
5. | The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): |
(a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and |
(b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
By: |
/s/Paul Schubert Paul Schubert Chief Financial Officer and Treasurer |
Date: | September 22, 2015 |